Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Terminated 3Completed 3Withdrawn 1Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 3Head & Neck 3

Conditions

Carcinoma, Non-Small-Cell Lung 233Head and Neck Neoplasms 150Squamous Cell Carcinoma of Head and Neck 136Stomach Neoplasms 117Lung Neoplasms 109Esophageal Neoplasms 90Uterine Cervical Neoplasms 72Neoplasms 67Urinary Bladder Neoplasms 56Breast Neoplasms 48Ovarian Neoplasms 46Esophageal Squamous Cell Carcinoma 45Pancreatic Neoplasms 44Small Cell Lung Carcinoma 42Neoplasm Metastasis 40Adenocarcinoma Of Esophagus 38Carcinoma, Squamous Cell 33Carcinoma, Ovarian Epithelial 32Mesothelioma, Malignant 30Parkinson Disease 4, Autosomal Dominant Lewy Body 28Lymphoma 28Adenocarcinoma of Lung 25Sarcoma 24Cholangiocarcinoma 24Nasopharyngeal Carcinoma 22Carcinoma 22Unspecified Adult Solid Tumor, Protocol Specific 21Neuroblastoma 21Gallbladder Neoplasms 21Central Nervous System Neoplasms 21

Interventions

Radiotherapy 6Fibroblast Growth Factor 7 4Injections 3Drug Therapy 3Cisplatin 3Water 2Propolis 2Mouthwashes 2Morphine 2Methotrexate 2Melphalan 2Low-Level Light Therapy 2Interleukin 1 Receptor Antagonist Protein 2Gabapentin 2Cryotherapy 2peppermint oil 1pegaspargase 1oxycodone-acetaminophen 1nelarabine 1kang-lai-te 1glucarpidase 1fludarabine phosphate 1fish oil triglycerides 1cyclohexaneacetic acid 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1acetaminophen, hydrocodone drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Mucositis × Cisplatin × Clear all
NCT03515538 2024-11-04

PREVLAR

EpicentRx, Inc.

Phase 2 Completed
53 enrolled 15 charts
Head & NeckOther

Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT02990468 2023-03-15

BMX-HN

BioMimetix JV, LLC

Phase 1/2 Completed
29 enrolled 14 charts
Head & NeckOther

Head and Neck Neoplasms, Xerostomia, Mucositis

NCT00626639 2017-06-21

A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy

Swedish Orphan Biovitrum

Phase 1/2 Completed
5 enrolled 8 charts
Head & NeckOther

Head and Neck Neoplasms, Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡